NEW YORK, April 27, 2021 /CNW/ — MindMed (Nasdaq: MNMD, NEO: MMED, DE: MMQ), a leading psychedelic medicine biotech company, is pleased to announce the start of trading on The Nasdaq Capital Market (“Nasdaq”). Trading will begin on Tuesday, April 27, 2021, under the symbol “MNMD” on the Nasdaq. As a reminder, MindMed will retain its listing on the Neo Exchange Inc. under the symbol “MMED”.
